Page last updated: 2024-10-30
metformin and ACD-MPV
metformin has been researched along with ACD-MPV in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Rana, U | 1 |
| Callan, E | 1 |
| Entringer, B | 1 |
| Michalkiewicz, T | 1 |
| Joshi, A | 1 |
| Parchur, AK | 1 |
| Teng, RJ | 1 |
| Konduri, GG | 1 |
Other Studies
1 other study available for metformin and ACD-MPV
| Article | Year |
|---|---|
AMP-Kinase Dysfunction Alters Notch Ligands to Impair Angiogenesis in Neonatal Pulmonary Hypertension.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Animals, Newborn; Biphenyl Compounds; Ductus Arterios | 2020 |